首页 | 本学科首页   官方微博 | 高级检索  
     

可条件性诱导PLK1稳定敲降的食管癌细胞株的建立
引用本文:曹迎亚,车轶群,陈群,马文韬,刘洋,郝佳洁,蔡岩,鲁卫华,王明荣,张钰,ZHANG Yu. 可条件性诱导PLK1稳定敲降的食管癌细胞株的建立[J]. 癌变.畸变.突变, 2014, 0(5): 348-352. DOI: 10.3969/j.issn.1004-616x.2014.05.006
作者姓名:曹迎亚  车轶群  陈群  马文韬  刘洋  郝佳洁  蔡岩  鲁卫华  王明荣  张钰  ZHANG Yu
作者单位:中国医学科学院肿瘤医院肿瘤研究所,分子肿瘤学国家重点实验室,北京 100021
基金项目:国家自然科学基金重点项目(项目编号:81330052)国家自然科学基金-创新研究群体科学基金(项目编号:81321091)国家高技术研究发展规划(863计划)项目(项目编号:2012AA02A503)
摘    要:目的: 建立可条件性诱导PLK1-shRNA稳定表达的食管癌细胞株,为深入研究PLK1在食管癌发生发展中的作用及分子机制提供细胞模型。方法:合成PLK1-shRNA寡核苷酸,退火后连接到慢病毒表达载体pLKO-Tet-On并转化至感受态细胞Stbl3,利用菌落PCR和测序分析鉴定阳性重组子。用pLKO-shPLK1-Tet-On重组质粒和包装质粒共转染293T细胞,收集病毒上清,感染食管癌细胞KYSE510,利用嘌呤霉素筛选可诱导PLK1-shRNA稳定表达的细胞株。采用qRT-PCR和Western blot检测强力霉素(Dox)诱导PLK1-shRNA表达的效率。结果:菌落PCR和测序分析结果显示,pLKO-shPLK1-Tet-On重组质粒中PLK1-shRNA的序列及插入位点正确。包装、收获病毒并感染KYSE510细胞后,筛选获得了具有嘌呤霉素抗性的稳定细胞株KYSE510-shPLK1-Tet-On。qRT-PCR和Western blot的检测结果显示,0.1 μg/mL Dox即可显著下调KYSE510-shPLK1-Tet-On细胞中PLK1的表达。结论:成功构建了诱导型PLK1-shRNA慢病毒表达载体,并筛选获得了可条件性诱导PLK1稳定敲降的食管癌细胞株,为进一步探讨PLK1异常表达与食管癌发生发展的关系提供了理想的细胞模型。

关 键 词:PLK1  shRNA  诱导表达  慢病毒载体  食管癌  
收稿时间:2014-04-01

Establishment of an esophageal cell line with stable expression of inducible PLK1-shRNA
CAO Ying-ya,CHE Yi-qun,CHEN Qun,MA Wen-tao,LIU Yang,HAO Jia-jie,CAI Yan,LU Wei-hua,WANG Ming-rong,ZHANG Yu. Establishment of an esophageal cell line with stable expression of inducible PLK1-shRNA[J]. Carcinogenesis,Teratogenesis and Mutagenesis, 2014, 0(5): 348-352. DOI: 10.3969/j.issn.1004-616x.2014.05.006
Authors:CAO Ying-ya  CHE Yi-qun  CHEN Qun  MA Wen-tao  LIU Yang  HAO Jia-jie  CAI Yan  LU Wei-hua  WANG Ming-rong  ZHANG Yu
Affiliation:State Key Laboratory of Molecular Oncology, Cancer Institute of Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100021
Abstract:OBJECTIVE: The aim of the study was to establish a suitable cell model for investigating the role and mechanism of PLK1 overexpression in esophageal cancer through inactivation of PLK1 expression employing lentiviral-mediated inducible shRNA expression system. METHODS:Chemically synthesized PLK1-shRNA oligonucleotides were annealed and ligated into the lentiviral vector pLKO-Tet-On. The ligation products were transformed into the competent E. coli Stbl3 cells. Colony PCR and sequencing analysis were used to identify the positive recombinants. The pLKO-shPLK1-Tet-On construct and packaging plasmids were co-transfected into 293T cells to produce the lentiviral particles. Esophageal cancer cells KYSE510 were infected with the viral supernatant and the stable cell strain was selected with puromycin. Doxcyclin-induced expression efficiency of PLK1-shRNA was determined by qRT-PCR and Western blotting. RESULTS:Colony PCR and sequencing analysis showed that PLK1-shRNA oligos were correctly inserted into the pLKO-Tet-On vector. The stable cell strain KYSE510-shPLK1-Tet-On was obtained through infecting the lentivirus expressing inducible PLK1-shRNA and then selected with puromycin. The results of qRT-PCR and Western blotting indicated that the expression of PLK1 in KYSE510-shPLK1-Tet-On cells could be markedly downregulated by 0.1 μg/mL Dox. CONCLUSION:We successfully constructed a lentivirus-based inducible PLK1-shRNA expression vector and established an esophageal cancer cell line with stable expression of inducible PLK1-shRNA,providing an ideal cell model for further exploring the relationship between aberrant PLK1 expression and development and progression of esophageal cancer.
Keywords:PLK1  shRNA  inducible expression  lentivirus expression vector  esophageal cancer
本文献已被 万方数据 等数据库收录!
点击此处可从《癌变.畸变.突变》浏览原始摘要信息
点击此处可从《癌变.畸变.突变》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号